Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F6QLE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,065
Award facts
- Contract value 100% obligated
- $21,064.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 27, 2026, the Defense Logistics Agency awarded a delivery order valued at $21,064.56 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (quantity: 8 units). This firm fixed-price delivery order, with an ultimate completion date of January 28, 2026, represents a competitive award with no set-aside designation. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs for military and veteran healthcare systems. The company's performance location for this order is its corporate office in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for acute migraine treatment, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products delivered through the Defense Logistics Agency's medical supply chain, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F6QLE?
SPE2DR26F6QLE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F6QLE worth?
The government has obligated $21,065 on SPE2DR26F6QLE.
Is contract SPE2DR26F6QLE an order under another contract?
Yes. SPE2DR26F6QLE is a delivery order under SPE2DR25D3801, an indefinite delivery contract.
Was contract SPE2DR26F6QLE competed?
The extent of competition for SPE2DR26F6QLE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award